4th Quarter - Report

DARDEN RESTAURANTS, INC. for DARDEN RESTAURANTS, INC

Firm
Client
Income
—
Expenses
$320,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Agriculture AGR

Biofuels issues; Renewable Fuels Standard; Volumetric Ethanol Excise Tax Credit

LobbyistCovered position, as disclosed
GERALD RALPH KUNDE —

Contacted: White House Office; SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Policy Development

Taxation/Internal Revenue Code TAX

Corporate tax reform; FICA tax tip credit; Work Opportunity Tax Credit; charitable deduction for food donations; in support of H.R. 3729; in support of H.R. 1265 and S. 687; in general support of tax extenders package

LobbyistCovered position, as disclosed
TYLER BIRKEL —
GERALD RALPH KUNDE —

Contacted: Office of Policy Development; Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; White House Office

Bills named: H.R. 3729 (112th), S. 687 (112th), H.R. 1265 (112th)

Telecommunications TEC

Delay of plan by the Internet Corporation for Assigned Names and Numbers to expand the amount of available top level domain names

LobbyistCovered position, as disclosed
TYLER BIRKEL —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Office of Policy Development

Health Issues HCR

Health care regulations directed by the Affordable Care Act (definition of full time employee; menu labeling provisions); FDA Sodium Docket; Darden Health and Wellness initiative

LobbyistCovered position, as disclosed
TYLER BIRKEL —
GERALD RALPH KUNDE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); White House Office; Office of Policy Development

Immigration IMM

S. 1196; in support of H.R. 2164; stating general support for a federal E-Verify mandate under certain conditions

LobbyistCovered position, as disclosed
TYLER BIRKEL —
GERALD RALPH KUNDE —

Contacted: Office of Policy Development; SENATE; White House Office; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 1196 (112th), H.R. 2164 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.